51
|
Hollander AA, de Waal LP, van Bockel HJ, Jonker M, Claas FH, van der Voort Maarschalk MF, Bruijn JA, van der Woude FJ. No tolerance induction with cryopreserved bone marrow cells after allogeneic kidney transplantation and antilymphocyte globulin in rhesus monkeys. Transpl Int 1997; 10:249-50. [PMID: 9163871 DOI: 10.1007/s001470050053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
|
52
|
Schuurman HJ, Hengy JC, Ringers J, Vonderscher J, Schuler W, Jonker M. Neoral pharmacokinetics in cynomolgus monkeys: relation to efficacy in renal allografting. Transplant Proc 1996; 28:3142-4. [PMID: 8962218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
|
53
|
Leonard AA, Jonker M, Lagaaij EL. Complete withdrawal of immunosuppression in allograft recipients. A study in rhesus monkeys. Transplantation 1996; 61:1648-51. [PMID: 8669112 DOI: 10.1097/00007890-199606150-00017] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
The influence of pretransplant blood transfusions on kidney allograft survival after cessation of immunosuppressive treatment was studied in 11 rhesus monkeys. The animals were conditioned by three pretransplant blood transfusions. After an induction treatment with cyclosporine (CsA), the immunosuppression was stopped and the natural course of the graft was followed. In two monkeys long-term graft survival without immunosuppression was obtained (2.5 and 4.25 years). In a third monkey, permanent allograft acceptance was achieved after complete cessation of immunosuppression. The monkey is still alive with a well-functioning graft for more than 13 years after cessation of immunosuppression. This monkey had received CsA for 12 months, two MHC DR-matched blood transfusions, and no repeated mismatches between graft and blood transfusion donors. We speculate that blood transfusions may influence allograft function in two opposite ways. As reported previously in man, MHC class-II-matched transfusions appear to beneficially influence allograft survival. This effect seems to be negated by a mismatched MHC class II antigen in the blood transfusion donor which is also present in the organ donor -- a so-called repeated mismatch. Further studies in rhesus monkeys are required to confirm and extend these results. In the future, these observations might help in developing a protocol that opens up the possibility of cessation of immunosuppression in transplant patients.
Collapse
|
54
|
Neville DM, Scharff J, Hu HZ, Rigaut K, Shiloach J, Slingerland W, Jonker M. A new reagent for the induction of T-cell depletion, anti-CD3-CRM9. JOURNAL OF IMMUNOTHERAPY WITH EMPHASIS ON TUMOR IMMUNOLOGY : OFFICIAL JOURNAL OF THE SOCIETY FOR BIOLOGICAL THERAPY 1996; 19:85-92. [PMID: 8732691 DOI: 10.1097/00002371-199603000-00001] [Citation(s) in RCA: 73] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
We have developed a new reagent for inducing in vivo T-cell depletion and have tested this reagent in rhesus monkeys. The reagent is an anti-CD3 epsilon immunotoxin based on a diphtheria toxin binding-site mutant, CRM9. After administration to monkeys, T cells are depleted from both the blood and lymph node compartments to < 1% of their initial values. T-cell depletion is associated with transient immunosuppression, as judged by delayed rejection of RhLA-mismatched skin allografts. T cells are repopulated in both compartments; however, the rate of repopulation is age dependent. The rate is rapid in juvenile animals (12 days) and requires > 30 days in old animals. The correlation between repopulation rate and age suggests that the repopulation is thymus dependent and that the repopulated T cells are probably naive T cells. This reagent should be a valuable tool in studying the role of memory T cells in rhesus models of autoimmune diseases and protocols of tolerance induction after organ transplantation.
Collapse
|
55
|
Herz RC, Jonker M, Verheul HB, Hillen B, Versteeg DH, de Wildt DJ. Middle cerebral artery occlusion in Wistar and Fischer-344 rats: functional and morphological assessment of the model. J Cereb Blood Flow Metab 1996; 16:296-302. [PMID: 8594062 DOI: 10.1097/00004647-199603000-00015] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
Cerebral infarction volume after occlusion of a short proximal segment of the middle cerebral artery (MCA) is reported to be different in Wistar compared to Fischer-344 (F344) rats, in both size and variability. Knowledge about the cause of these differences might enable us to explain and perhaps reduce the variation in infarct volume and create a reproducible model of focal cerebral ischemia in the rat. We investigated in Wistar and F344 rats both the effect of occlusion of a long proximal MCA segment on cerebral infarction volume, visualized by magnetic resonance imaging and histology, and the morphology of the major cerebral arteries. Occlusion of a long proximal MCA segment resulted in a striatal and a small cortical infarction in Wistar and a striatal and sizable cortical infarction in F344 rats (as is the case after occlusion of a short proximal MCA segment). In Wistar rats, however, occlusion of a long proximal MCA segment strongly reduced the variability in infarction volume in comparison to occlusion of a small proximal MCA segment. Analysis of the morphology of the major cerebral arteries showed a significantly higher number of proximal side branches of the long proximal MCA segment in Wistar rates than in F344 rats. We conclude that after short-segment proximal MCA occlusion, extreme variability in cerebral infarction volume in Wistar rats compared to F344 rats may be attributable to a significantly greater number of proximal MCA side branches in Wistar rats than in F344 rats.
Collapse
|
56
|
Abreu P, Adam W, Adye T, Agasi E, Ajinenko I, Aleksan R, Alekseev GD, Allport PP, Almehed S, Almeida FML, Alvsvaag SJ, Amaldi U, Andreazza A, Antilogus P, Apel WD, Apsimon RJ, Arnoud Y, Asman B, Augustin JE, Augustinus A, Baillon P, Bambade P, Barao F, Barate R, Bardin DY, Barker GJ, Baroncelli A, Barring O, Barrio JA, Bartl W, Bates MJ, Battaglia M, Baubillier M, Baudot J, Becks KH, Begalli M, Beilliere P, Beltran P, Benvenuti AC, Berggren M, Bertrand D, Bianchi F, Bigi M, Bilenky MS, Billoir P, Bjarne J, Bloch D, Blocki J, Blyth S, Bocci V, Bogolubov PN, Bolognese T, Bonesini M, Bonivento W, Booth PSL, Borisov G, Bosio C, Bostjancic B, Bosworth S, Botner O, Boudinov E, Bouquet B, Bourdarios C, Bowcock TJV, Bozzo M, Braibant S, Branchini P, Brand KD, Brenner RA, Briand H, Bricman C, Brillault L, Brown RCA, Brunet JM, Bugge L, Buran T, Buys A, Buytaert JAMA, Caccia M, Calvi M, Camacho Rozas AJ, Campion R, Camporesi T, Capale V, Cankocak K, Cao F, Carena F, Carrilho P, Carroll L, Cases R, Caso C, Castillo Gimenez MV, Cattai A, Cavallo FR, Cerrito L, Chabaud V, Chan A, Chapkin M, Charpentier P, Chaussard L, Chauveau J, Checchia P, Chelkov GA, Chliapnikov P, Chorowicz V, Chrin JTM, Cindro V, Collins P, Contreras JL, Contri R, Cortina E, Cosme G, Cosmo G, Cossutti C, Couchot F, Crawley HB, Crennell D, Crosetti G, Cuevas Maestro J, Czellar S, Dahl-Jensen E, Dahm J, Dalmagne B, Dam M, Damgaard G, Daubie E, Daum A, Dauncey PD, Davenport M, Davies J, Silva W, Defoix C, Delpierre P, Demaria N, Angelis A, Boeck H, Boer W, Brabandere S, Clercq C, Fez Laso MDM, Vaissiere C, Lotto B, Min A, Paula L, Saint-Jean C, Diikstra H, Ciaccio L, Diama F, Dolbeau J, Donszelmann M, Doroba K, Dracos M, Drees J, Dris M, Dufour Y, Dupont F, Edsall D, Ehret R, Ekelof T, Ekspong G, Elsing M, Engel JP, Ershaidat N, Espirito Santo M, Fassouliotis D, Feindt M, Fenyuk A, Ferrer A, Filippas TA, Firestone A, Foeth H, Fokitis E, Fontanelli F, Formenti F, Fousset JL, Franek B, Frenkiel P, Fries DC, Frodesen AG, Fruhwirth R, Fulda-Quenzer F, Furstenau H, Fuster J, Gamba D, Gandelman M, Garcia C, Garcia J, Gaspar C, Gasparini U, Gavillet P, Gazis EN, Gele D, Gerber JP, Giacomelli P, Gillespie D, Gokieli R, Golob B, Golovatyuk VM, Gomez Y Cadenas JJ, Gopal G, Gorn L, Gorski M, Gracco V, Grard F, Graziani E, Grosdidier G, Gunnarsson P, Guy J, Haedinger U, Hahn F, Hahn M, Hahn S, Haider S, Hajduk Z, Hakansson A, Hallgren A, Hamacher K, Hao W, Harris FJ, Hedberg V, Henriques R, Hernandez JJ, Hernando JA, Herquet P, Herr H, Hessing TL, Higon E, Hilke HJ, Hill TS, Holmgren SO, Holt PJ, Holthuizen D, Honore PF, Houlden M, Hrubec J, Huet K, Hultqvist K, Ioannou P, Iversen PS, Jackson JN, Jacobsson R, Jalocha P, Jarlskog G, Jarry P, Jean-Marie B, Johansson EK, Jonker M, Jonsson L, Juillot P, Kaiser M, Kalmus G, Kapusta F, Karlsson M, Karvelas E, Katsanevas S, Katsoufis EC, Keranen R, Khomenko BA, Khovanski NN, King B, Kjaer NJ, Klein H, Klovning A, Kluit P, Koch-Mehrin A, Koehne JH, Koene B, Kokkinias P, Koratzinos M, Korcyl K, Korytov AV, Kostioukhine V, Kourkoumelis C, Kouznetsov O, Kramer PH, Krammer M, Kreuter C, Krolikowski J, Kronkvist I, Krupinski W, Kulka K, Kurvinen K, Lacasta C, Laktineh I, Lambropoulos C, Lamsa JW, Lanceri L, Langefeld P, Lapin V, Last I, Laugier JP, Lauhakangas R, Leder G, Ledroit F, Leitner R, Lemoigne Y, Lemonne J, Lenzen G, Lepeltier V, Lesiak T, Levy JM, Lieb E, Liko D, Lindner R, Lipniacka A, Lippi I, Loerstad B, Lokajicek M, Loken JG, Lopez-Fernandez A, Lopez Aguera MA, Los M, Loukas D, Lozano JJ, Lutz P, Lyons L, Maehlum G, Maillard J, Maio A, Maltezos A, Mandl F, Marco J, Marechal B, Margoni M, Marin JC, Mariotti C, Markou A, Maron T, Marti S, Martinez-Rivero C, Martinez-Vidal F, Matorras F, Matteuzzi C, Matthiae G, Mazzucato M, Cubbin MM, Kay RM, Nulty RM, Medbo J, Meroni C, Meyer WT, Michelotto M, Migliore E, Mikulec I, Mirabito L, Mitaroff WA, Mitselmakher GV, Mjoernmark U, Moa T, Moeller R, Moenig K, Monge MR, Morettini P, Mueller H, Murray WJ, Muryn B, Myatt G, Naraghi F, Navarria FL, Negri P, Nemecek S, Neumann R, Nicolaidou R, Nielsen BS, Niss P, Nomerotski A, Normand A, Obraztsov V, Olshevski AG, Orava R, Osterberg K, Ouraou A, Paganini P, Paganoni M, Pain R, Palka H, Papadopoulou TD, Pape L, Parodi F, Passeri A, Pegararo M, Pennanen J, Peralta L, Pernegger H, Pernicka M, Perrotta A, Petridou C, Petrolini A, Phillips HT, Piana G, Pierre F, Pimenta M, Plaszczynski S, Podobrin O, Pol ME, Polok G, Poropat P, Pozdniakov V, Prest M, Privitera P, Pullia A, Radojicic D, Ragazzi S, Rahmani H, Rames J, Ratoff PN, Read AL, Reale M, Rebecchi P, Redaelli NG, Regler M, Reid D, Renton PB, Resvanis LK, Richard F, Richardson J, Ridky J, Rinaudo G, Ripp I, Romero A, Roncagliolo I, Ronchese P, Roos L, Rosenberg EI, Rosso E, Roudeau P, Rovelli T, Ruckstuhl W, Ruhlmann-Kleider V, Ruiz A, Rybicki K, Saarikko H, Sacquin Y, Sajot G, Salt J, Sanchez J, Sannino M, Schael S, Schneider H, Schyns MAE, Sciolla G, Scuri F, Segar AM, Seitz A, Sekulin R, Seufert R, Shellard RC, Siccama I, Siegrist P, Simonetti S, Simonetto F, Sisakian AN, Skaali TB, Smadja G, Smirnov N, Smirnova O, Smith GR, Sosnowski R, Souza-Santos D, Spassov T, Spiriti E, Squarcia S, Staeck H, Stanescu C, Stapnes S, Stavitski I, Stavropoulos G, Stepaniak K, Stichelbaut F, Stocchi A, Strauss J, Straver J, Strub R, Stugu B, Szczekowski M, Szeptycka M, Tabarelli T, Tchikilev O, Theodosiou GE, Thome Z, Tilquin A, Timmermans J, Timofeev VG, Tkatchev LG, Todorov T, Toet DZ, Tomaradze A, Tome B, Torassa E, Tortora L, Transtromer G, Treille D, Trischuk W, Tristram G, Troncon C, Tsirou A, Tsyganov EN, Turala M, Turluer ML, Tuuva T, Tyapkin IA, Tyndel M, Tzamarias S, Ueberschaer B, Ueberschaer S, Ullaland O, Uvarov V, Valenti G, Vallazza E, Valls Ferrer JA, Velde C, Apeldoorn GW, Dam P, Heijden M, Doninck WK, Eldik J, Vaz P, Vegni G, Ventura L, Venus W, Verbeure F, Verlato M, Vertogradov LS, Vilanova D, Vincent P, Vitale L, Vlasov E, Vodopyanov AS, Vollmer M, Voutilainen M, Wahlen H, Walck C, Wehr A, Weierstall M, Weilhammer P, Wetherell AM, Wickens JH, Wielers M, Wilkinson GR, Williams WSC, Winter M, Witek M, Wormser G, Woschnagg K, Yip K, Yushchenko O, Zach F, Zaitsev A, Zalewska A, Zalewski P, Zavrtanik D, Zevgolatakos E, Zimin NI, Zito M, Zontar D, Zuberi R, Zumerle G. A study of radiative muon-pair events at Z0 energies and limits on an additional Z′ gauge beson. ACTA ACUST UNITED AC 1995. [DOI: 10.1007/bf01578669] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
57
|
Kraakman EM, Bontrop RE, Groenestein R, Jonker M, Haaijman JJ, t Hart BA. Characterization of the natural immune response of rhesus monkey CD4+ve T cells to the bacterial antigen streptolysin O (SLO). J Med Primatol 1995; 24:306-12. [PMID: 8750506 DOI: 10.1111/j.1600-0684.1995.tb00183.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Rhesus monkeys show a high proliferative T cell response to the bacterial exotoxin SLO without prior immunization. The present study was undertaken to characterize this naturally present SLO-responsiveness with particular emphasis on CD4+ve reactive T cells. It is demonstrated that the frequency of SLO-reactive cells in the circulation.ranges between 1 in 75 and 1 in 610 CD4+ve T cells as determined with limiting dilution analysis. It is also shown that induction of a good proliferative response requires Mhc-DR matching between T cell and the antigen presenting cells (APC). Stable and DR-restricted SLO-specific CD4+ve T cell lines were generated from CD8 depleted peripheral blood mononuclear cells (PBMC). The SLO-reactive CD4+ve cell lines are tentatively characterized as Th1-like based on the predominant production of interferon-gamma (IFN-gamma) over IL-4, although this seems contradicted by the IL-4 dependent growth of the lines.
Collapse
|
58
|
Abreu P, Adam W, Adye T, Agasi E, Ajinenko I, Aleksan R, Alekseev GD, Allport PP, Almehed S, Almeida FML, Alvsvaag SJ, Amaldi U, Andreazza A, Antilogus P, Apel WD, Apsimon RJ, Arnoud Y, Asman B, Augustin JE, Augustinus A, Baillon P, Bambade P, Barao F, Barate R, Barbiellini G, Bardin DY, Barker GJ, Baroncelli A, Barring O, Barrio JA, Bartl W, Bates MJ, Battaglia M, Baubillier M, Baudot J, Becks KH, Begalli M, Beilliere P, Belokopytov Y, Beltran P, Benvenuti AC, Berggren M, Bertrand D, Bianchi F, Bigi M, Bilenky MS, Billoir P, Bjarne J, Bloch D, Blocki J, Blyth S, Bocci V, Bogolubov PN, Bolognese T, Bonesini M, Bonivento W, Booth PSL, Borisov G, Bosio C, Bostjancic B, Bosworth S, Botner O, Bouquet B, Bourdarios C, Bowcock TJV, Bozzo M, Braibant S, Branchini P, Brand KD, Brenner RA, Briand H, Bricman C, Brillault L, Brown RCA, Bruckman P, Brunet JM, Bugge L, Buran T, Buys A, Buytaert JAMA, Caccia M, Calvi M, Camacho Rozas AJ, Campion R, Camporesi T, Canale V, Cankocak K, Cao F, Carena F, Carrilho P, Carroll L, Cases R, Caso C, Castillo Gimenez MV, Cattai A, Cavallo FR, Cerrito L, Chabaud V, Chan A, Charpentier P, Chaussard L, Chauveau J, Checchia P, Chelkov GA, Chliapnikov P, Chorowicz V, Chrin JTM, Cindro V, Collins P, Contreras JL, Contri R, Cortina E, Cosme G, Couchot F, Crawley HB, Crennell D, Crosetti G, Maestro JC, Czellar S, Dahl-Jensen E, Dahm J, Dalmagne B, Dam M, Damgaard G, Daubie E, Daum A, Dauncey PD, Davenport M, Davies J, Silva W, Defoix C, Delpierre P, Demaria N, Angelis A, Boeck H, Boer W, Brabandere S, Clercq C, Fez Laso MDM, Vaissiere C, Lotto B, Min A, Paula L, Saint-Jean C, Dijkstra H, Ciaccio L, Djama F, Dolbeau J, Donszelmann M, Doroba K, Dracos M, Drees J, Dris M, Dufour Y, Dupont F, Edsall D, Ehret R, Ekelof T, Ekspong G, Elsing M, Engel JP, Ershaidat N, Santo ME, Fassouliotis D, Feindt M, Fenyuk A, Ferrer A, Fillippas TA, Firestone A, Foeth H, Fokitis E, Fontanelli F, Formenti F, Fousset JL, Franek B, Frenkiel P, Fries DC, Frodesen AG, Fruhwirth R, Fulda-Quenzer F, Furstenau H, Fuster J, Gamba D, Gandelman M, Garcia C, Garcia J, Gaspar C, Gasparini U, Gavillet P, Gazis EN, Gele D, Gerber JP, Giacomelli P, Gillespie D, Gokieli R, Golob B, Golovatyuk VM, Gomez Y Cadenas JJ, Gopal G, Gorn L, Gorski M, Gracco V, Grard F, Graziani E, Grosdidier G, Gunnarsson P, Guy J, Haedinger U, Hahn F, Hahn M, Hahn S, Haider S, Hajduk Z, Hakansson A, Hallgren A, Hamacher K, Hao W, Harris FJ, Hedberg V, Henriques R, Hernandez JJ, Hernando JA, Herquet P, Herr H, Hessing TL, Higon E, Hilke HJ, Hill TS, Holmgren SO, Holt PJ, Holthuizen D, Honore PF, Houlden M, Hrubec J, Huet K, Hultqvist K, Ioannou P, Iversen PS, Jackson JN, Jacobsson R, Jalocha P, Jarlskog G, Jarry P, Jean-Marie B, Johansson EK, Jonker M, Jonsson L, Juillot P, Kaiser M, Kalmus G, Kapusta F, Karlsson M, Karvelas E, Katsanevas S, Katsoufis EC, Keranen R, Khomenko BA, Khovanski NN, King B, Kjaer NJ, Klein H, Klovning A, Kluit P, Koch-Mehrin A, Koehne JH, Koene B, Kokkinias P, Koratzinos M, Korytov AV, Kostioukhine V, Kourkoumelis C, Kouznetsov O, Kramer PH, Krammer M, Kreuter C, Krolikowski J, Kronkvist I, Krupinski W, Kucewicz W, Kulka K, Kurvinen K, Lacasta C, Laktineh I, Lambropoulos C, Lamsa JW, Lanceri L, Langefeld P, Lapin V, Last I, Laugier JP, Lauhakangas R, Leder G, Ledroit F, Leitner R, Lemoigne Y, Lemonne J, Lenzen G, Lepeltier V, Lesiak T, Levy JM, Lieb E, Liko D, Lindner R, Lipniacka A, Lippi I, Loerstad B, Lokajicek M, Loken JG, Lopez-Fernandez A, Lopez Aguera MA, Los M, Loukas D, Lozano JJ, Lutz P, Lyons L, Maehlum G, Maillard J, Maio A, Maltezos A, Marco J, Marechal B, Margoni M, Marin JC, Mariotti C, Markou A, Maron T, Marti S, Martinez-Rivero C, Martinez-Vidal F, Matorras F, Matteuzzi C, Matthiae G, Mazzucato M, Cubbin MM, Kay RM, Nulty RM, Medbo J, Meroni C, Meyer WT, Michelotto M, Migliore E, Mikulec I, Mirabito L, Mitaroff WA, Mitselmakher GV, Mjoernmark U, Moa T, Moeller R, Moenig K, Monge MR, Morettini P, Mueller H, Murray WJ, Muryn B, Myatt G, Naraghi F, Navarria FL, Negri P, Nemecek S, Neumann W, Neumeister N, Nicolaidou R, Nielsen BS, Nikolaenko V, Niss P, Nomerotski A, Normand A, Obraztsov V, Olshevski AG, Orava R, Osterberg K, Ouraou A, Paganini P, Paganoni M, Pain R, Palka H, Papadopoulou TD, Pape L, Parodi F, Passeri A, Pegoraro M, Pennanen J, Peralta L, Perevozchikov V, Pernegger H, Pernicka M, Perrotta A, Petridou C, Petrolini A, Phillips HT, Piana G, Pierre F, Pimenta M, Plaszczynski S, Podobrin O, Pol ME, Polok G, Poropat P, Pozdniakov V, Prest M, Privitera P, Pullia A, Radojicic D, Ragazzi S, Rahmani H, Rames J, Ratoff PN, Read AL, Reale M, Rebecchi P, Redaelli NG, Regler M, Reid D, Renton PB, Resvanis LK, Richard F, Richardson J, Ridky J, Rinaudo G, Ripp I, Romero A, Roncagliolo I, Ronchese P, Ronjin V, Roos L, Rosenberg EI, Rosso E, Roudeau P, Rovelli T, Ruckstuhl W, Ruhlmann-Kleider V, Ruiz A, Saarikko H, Sacquin Y, Sajot G, Salt J, Sanchez J, Sannino M, Schael S, Schneider H, Schyns MAE, Sciolla G, Scuri F, Segar AM, Seitz A, Sekulin R, Sessa M, Seufert R, Shellard RC, Siccama I, Siegrist P, Simonetti S, Simonetto F, Sisakian AN, Skaali TB, Smadja G, Smirnov N, Smirnova O, Smith GR, Sosnowski R, Douza-Santos D, Spassov T, Spiriti E, Squarcia S, Staeck H, Stanescu C, Stapnes S, Stavitski I, Stavropoulos G, Stepaniak K, Stichelbaut F, Stocchi A, Strauss J, Straver J, Strub R, Stugu B, Szczekowski M, Szeptycka M, Tabarelli T, Tchikilev O, Theodosiou GE, Thome Z, Tilquin A, Timmermans J, Timofeev VG, Tkatchev LG, Todorov T, Toet DZ, Tomaradze A, Tome B, torassa E, Tortora L, Transtromer G, Treille D, Tristram G, Troncon C, Tsirou A, Tsyganov EN, Turluer ML, Tuuva T, Tyapkin IA, Tyndel M, Tzamarias S, Ueberschaer B, Ueberschaer S, Ullaland O, Uvarov V, Valenti G, Vallazza E, Valls Ferrer JA, Velde C, Apeldoorn GW, Dam P, Heijden M, Doninck WK, Eldik J, Vaz P, Vegni G, Ventura L, Venus W, Verbeure F, Verlato M, Vertogradov LS, Vilanova D, Vincent P, Vitale L, Vlasov E, Vodopyanov AS, Vollmer M, Voutilainen M, Vrba V, Wahlen H, Walck C, Waldner F, Wehr A, Weierstall M, Weilhammer P, Wetherell AM, Wickens JH, Wielers M, Wilkinson GR, Williams WSC, Winter M, Witek M, Wormser G, Woschnagg K, Yip K, Yushchenko O, Zach F, Zaitsev A, Zalewska A, Zalewski P, Zavrtanik D, Zevgolatakos E, Zimin NI, Zito M, Zontar D, Zuberi R, Zumerle G. Measurement of the $$\Gamma _{b\bar b} /\Gamma _{had} $$ branching ratio of thez by double hemisphere tagging. ACTA ACUST UNITED AC 1995. [DOI: 10.1007/bf01578666] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
59
|
Slierendregt BL, Hall M, 't Hart B, Otting N, Anholts J, Verduin W, Claas F, Jonker M, Lanchbury JS, Bontrop RE. Identification of an Mhc-DPB1 allele involved in susceptibility to experimental autoimmune encephalomyelitis in rhesus macaques. Int Immunol 1995; 7:1671-9. [PMID: 8562513 DOI: 10.1093/intimm/7.10.1671] [Citation(s) in RCA: 40] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
Experimental autoimmune encephalomyelitis (EAE) is an inducible autoimmune disorder that in rodents is known to be influenced by genetic background, specifically the Mhc class II region. Immunization of a group of outbred rhesus macaques with bovine high homogenate results in induction of the disease in approximately 65% of the animals. No clear association between the Mamu-DR or -DQ subregion of the rhesus macaque MHC (MhcMamu) and susceptibility or resistance to the disease has been documented. In this communication we describe a CD4+ Th cell line, isolated from an animal diagnosed with EAE, which proliferated in response to purified bovine myelin basic protein (MBP), a major constituent of the myelin sheath surrounding nerve cells. More specifically it only recognized a peptide including residues 61-82 of the molecule. Analysis of the T cell receptor (Tcr) usage of this MBP reactive T cell line showed functional transcripts for only two members of the V alpha 1 and one of each of the V beta 3 and V beta 6 families. The antigen-specific proliferative response was inhibited by a mAb reactive with MHC-DP molecules. Molecular analysis of the Mamu-DP region, in concert with allogeneic antigen presentation studies, demonstrated that the Mamu-DPB1*01 gene product functions as the restriction element for MBP peptide presentation. Retrospective analyses showed that this particular allele is frequently found in the group of EAE susceptible animals but is absent in the resistant animals (P < 0.01). As a consequence, the Mamu-DPB1*01 allele may represent one of the risk factors involved in determining susceptibility to EAE in an outbred population of rhesus macaques.
Collapse
|
60
|
Arnaudon L, Dehning B, Grosse-Wiesmann P, Jacobsen R, Jonker M, Koutchouk JP, Miles J, Olsen R, Placidi M, Schmidt R, Wenninger J, Assmann R, Blondel A. Accurate determination of the LEP beam energy by resonant depolarization. ACTA ACUST UNITED AC 1995. [DOI: 10.1007/bf01496579] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
61
|
Gramatzki M, Burger R, Strobel G, Trautmann U, Bartram CR, Helm G, Horneff G, Alsalameh S, Jonker M, Gebhart E. Therapy with OKT3 monoclonal antibody in refractory T cell acute lymphoblastic leukemia induces interleukin-2 responsiveness. Leukemia 1995; 9:382-90. [PMID: 7885036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
Administration of cytokines to patients with leukemia or lymphoma may recruit dormant malignant cells into cell cycle and thus make them more susceptible to chemotherapy. We treated a patient with refractory T cell acute lymphoblastic leukemia (ALL) with OKT3 monoclonal antibody and observed a dramatic but transient decrease of lymphoblasts. The T ALL cells were rather mature by morphology and immunophenotyping, expressing CD7, CD4, CD8 and CD3 surface antigens and nuclear TdT. Cytogenetic analysis revealed inversion of chromosome 14(q11q32.1). A total of 500 mg OKT3 (maximum dose 50 mg/day) was given. A decrease of lymphoblasts in the blood and a reduction of spleen size was observed. Complement levels dropped remarkably. Despite increasing serum levels of tumor necrosis factor, treatment was well tolerated overall. CD3 therapy induced strong IL-2 responsiveness of the lymphoblasts. Thus, OKT3 antibody treatment not only significantly decreased CD3-positive tumor cells, but also induced IL-2-mediated proliferation. This may also allow sequential application of CD3 and IL-2 to render certain T cell tumors more susceptible to chemotherapy.
Collapse
|
62
|
t Hart BA, Kraakman E, Jonker M. An ear swelling reaction for in vivo monitoring of inflammatory T cell activity in collagen-arthritic rats. J Immunol Methods 1994; 176:179-84. [PMID: 7983379 DOI: 10.1016/0022-1759(94)90312-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
T cells play a dominant role in the pathogenesis of collagen-induced arthritis (CIA). The effector mechanism involves a delayed-type hypersensitivity reaction in the synovial joint. Here we describe a new test system, named a flare reaction, to monitor directly this inflammatory T cell function. It is shown that type II collagen (CII) injected into the pinna of the ear is a target for CII-reactive inflammatory T cells formed during the early pathogenesis of CIA. The inflammatory swelling of the joint and the CII-injected ear in CIA rats develop in a coordinated manner. This assay greatly facilitates monitoring of in vivo activated inflammatory T cells during the induction of CIA.
Collapse
|
63
|
Abreu P, Adam W, Adye T, Agasi E, Aleksan R, Alekseev GD, Algeri A, Almehed S, Alvsvaag SJ, Amaldi U, Andreazza A, Antilogus P, Apel WD, Apsimon RJ, Arnoud Y, �sman B, Augustin JE, Augustinus A, Baillon P, Bambade P, Barao F, Barate R, Barbiellini G, Bardin DY, Barker GJ, Baroncelli A, Barring O, Barrio JA, Bates MJ, Battaglia M, Baubillier M, Becks KH, Begalli M, Beilliere P, Belokopytov Y, Beltran P, Benedic D, Benvenuti AC, Berggren M, Bertrand D, Bianchi F, Bigi M, Bilenky MS, Billoir P, Bjarne J, Bloch D, Blocki J, Blyth S, Bocci V, Bogolubov PN, Bolognese T, Bonesini M, Bonivento W, Booth PSL, Borisov G, Borner H, Bosio C, Bostjancic B, Bosworth S, Botner O, Bouquet B, Bourdarios C, Bowcock TJV, Bozzo M, Braibant S, Branchini P, Brand KD, Brenner RA, Briand H, Bricman C, Brillaut L, Brown RCA, Brunet JM, Budziak A, Bugge L, Buran T, Burmeister H, Buys A, Buytaert JAMA, Caccia M, Calvi M, Rozas AJC, Campion R, Camporesi T, Canale V, Cankocak K, Cao F, Carena F, Carroll L, Caso C, Gimenez MVC, Cattai A, Cavallo FR, Cerrito L, Chabaud V, Chan A, Chapkin M, Charpentier P, Chaussard L, Chauveau J, Checchia P, Chelkov GA, Chevalier L, Chliapnikov P, Chorowicz V, Chrin JTM, Cindro V, Collins P, Contreras JL, Contri R, Cortina E, Cosme G, Couchot F, Crawley HB, Crennell D, Crosetti G, Maestro JC, Czellar S, Dahl-Jensen E, Dahm J, Dalmagne B, Dam M, Damgaard G, Daubie E, Daum A, Dauncey PD, Davenport M, Davies J, Silva W, Defoix C, Delpierre P, Demaria N, Angelis A, Boeck H, Boer W, Brabandere S, Clerq C, Fez Laso MDM, Vaissiere C, Lotto B, Min A, Dijkstra H, Ciaccio L, Dolbeau J, Donszelmann M, Doroba K, Dracos M, Drees J, Dris M, Dufour Y, Dupont F, Edsall D, Eek LO, Eerola PAM, Ehret R, Ekelof T, Ekspong G, Peisert AE, Elsing M, Engel JP, Ershaidat N, Santo ME, Fassouliotis D, Feindt M, Ferrer A, Filippas TA, Firestone A, Foeth H, Fokitis E, Fontanelli F, Forbes KAJ, Fousset JL, Francon S, Franek B, Frenkiel P, Fries DC, Frodesen AG, Fruhwirth R, Fulda-Quenzer F, Furstenau H, Fuster J, Gamba D, Garcia C, Garcia J, Gaspar C, Gasparini U, Gavillet P, Gazis EN, Gerber JP, Giacomelli P, Gillespie D, Gokieli R, Golob B, Golovatyuk VM, Gomez Y Cadenas JJ, Gopal G, Gorn L, Gorski M, Gracco V, Grant A, Grard F, Graziani E, Grosdidier G, Gross E, Grossetete B, Gunnarsson P, Guy J, Haedinger U, Hahn F, Hahn M, Hahn S, Haider S, Hajduk Z, Hakansson A, Hallgren A, Hamacher K, Hamel De Monchenault G, Hao W, Harris FJ, Hedberg V, Henkes T, Henriques R, Hernandez JJ, Hernando JA, Herquet P, Herr H, Hessing TL, Hietanen I, Higgins CO, Higon E, Hilke HJ, Hill TS, Hodgson SD, Hofmokl T, Holmgren SO, Holt PJ, Holthuizen D, Honore PF, Houlden M, Hrubec J, Huet K, Hultqvist K, Ioannou P, Iversen PS, Jackson JN, Jacobsson R, Jalocha P, Jarlskog G, Jarry P, Jean-Marie B, Johansson EK, Jonker M, Jonsson L, Juillot P, Kalkanis G, Kalmus G, Kapusta F, Karlsson M, Karvelas E, Katsanevas S, Katsoufis EC, Keranen R, Khomenko BA, Khovanski NN, King B, Kjaer NJ, Klein H, Klovning A, Kluit P, Koch-Mehrin A, Koehne JH, Koene B, Kokkinias P, Koratzinos M, Korcyl K, Korytov AV, Kostioukhine V, Kourkoumelis C, Kouznetsov O, Kramer PH, Krammer M, Kreuter C, Krolikowski J, Kronkvist I, Kucewicz W, Kulka K, Kurvinen K, Lacasta C, Lambropoulos C, Lamsa JW, Lanceri L, Langefeld P, Lapin V, Last I, Laugier JP, Lauhakangas R, Leder G, Ledroit F, Leitner R, Lemoigne Y, Lemonne J, Lenzen G, Lepeltier V, Lesiak T, Levy JM, Lieb E, Liko D, Lindgren J, Lindner R, Lippi I, Loerstad B, Lokajicek M, Loken JG, Lopez-Fernandez A, Lopez Aguera MA, Los M, Loukas D, Lozano JJ, Lutz P, Lyons L, Maehlum G, Maillard J, Maio A, Maltezos A, Mandl F, Marco J, Margoni M, Marin JC, Markou A, Maron T, Marti S, Martinez-Rivero C, Martinez-Vidal F, Matorras F, Matteuzzi C, Matthiae G, Mazzucato M, Mc Cubbin M, McKay R, McNulty R, Medbo J, Meroni C, Meyer WT, Michelotto M, Mikulec I, Mirabito L, Mitaroff WA, Mitselmakher GV, Mjoernmark U, Moa T, Moeller R, Moenig K, Monge MR, Morettini P, Mueller H, Murray WJ, Myatt G, Navarria FL, Negri P, Nemecek S, Neumann W, Nicolaidou R, Nielsen BS, Nijjhar B, Nikolaenko V, Nilsen PES, Niss P, Nomerotski A, Obraztsov V, Olshevski AG, Orava R, Ostankov A, Osterberg K, Ouraou A, Paganoni M, Pain R, Palka H, Papadopoulou TD, Pape L, Parodi F, Passeri A, Pegoraro M, Pennanen J, Peralta L, Perevozchikov V, Pernegger H, Pernicka M, Perrotta A, Petridou C, Petrolini A, Piana G, Pierre F, Pimenta M, Plaszczynski S, Podobrin O, Pol ME, Polok G, Poropat P, Pozdniakov V, Privitera P, Pullia A, Radojicic D, Ragazzi S, Rahmani H, Rames J, Ratoff PN, Read AL, Reale M, Rebecchi P, Redaelli NG, Regler M, Reid D, Renton PB, Resvanis LK, Richard F, Richardson J, Ridky J, Rinaudo G, Roditi I, Romero A, Roncagliolo I, Ronchese P, Ronnqvist C, Rosenberg EI, Rosso E, Rovelli T, Ruckstuhl W, Ruhlmann-Kleider V, Ruiz A, Saarikko H, Sacquin Y, Sajot G, Salt J, Sanchez J, Sannino M, Schael S, Schneider H, Schyns MAE, Sciolla G, Scuri F, Segar AM, Seitz A, Sekulin R, Sessa M, Seufert R, Shellard RC, Siccama I, Siegrist P, Simonetti S, Simonetto F, Sisakian AN, Skjevling G, Smadja G, Smirnov N, Smirnova O, Smith GR, Sosnowski R, Souza-Santos D, Spassoff T, Spiriti E, Squarcia S, Staeck H, Stanescu C, Stapnes S, Stavropoulos G, Stichelbaut F, Stocchi A, Strauss J, Straver J, Strub R, Stugu B, Szczekowski M, Szeptycka M, Szymanski P, Tabarelli T, Tchikilev O, Theodosiou GE, Tilquin A, Timmermans J, Timofeev VG, Tkatchev LG, Todorov T, Toet DZ, Toker O, Tomaradze A, Tome B, Torassa E, Tortora L, Treille D, Trischuk W, Tristram G, Troncon C, Tsirou A, Tsyganov EN, Turluer ML, Tuuva T, Tyapkin IA, Tyndel M, Tzamarias S, Ueberschaer B, Ueberschaer S, Ullaland O, Uvarov V, Valenti G, Vallazza E, Valls Ferrer JA, Velde C, Apeldoorn GW, Dam P, Heijden M, Doninck WK, Eldik J, Vaz P, Vegni G, Ventura L, Venus W, Verbeure F, Verlato M, Vertogradov LS, Vilanova D, Vincent P, Vitale L, Vlasov E, Vodopyanov AS, Vollmer M, Voutilainen M, Vrba V, Wahlen H, Walck C, Waldner F, Wehr A, Weierstall M, Weilhammer P, Wetherell AM, Wickens JH, Wielers M, Wilkinson GR, Williams WSC, Winter M, Witek M, Wormser G, Woschnagg K, Zaitsev A, Zalewska A, Zalewski P, Zavrtanik D, Zevgolatakos E, Zimin NI, Zito M, Zontar D, Zuberi R, Zumerle G, Zuniga J. Production rate and decay lifetime measurements ofB s 0 mesons at LEP usingD s and? mesons. ACTA ACUST UNITED AC 1994. [DOI: 10.1007/bf01413179] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
64
|
Heeney JL, van Els C, de Vries P, ten Haaft P, Otting N, Koornstra W, Boes J, Dubbes R, Niphuis H, Dings M, Cranage M, Norley S, Jonker M, Bontrop RE, Osterhaus A. Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells. J Exp Med 1994; 180:769-74. [PMID: 8046353 PMCID: PMC2191582 DOI: 10.1084/jem.180.2.769] [Citation(s) in RCA: 53] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Abstract
To evaluate the effectiveness of vaccine protection from infected cells from another individual of the same species, vaccinated rhesus macaques (Macaca mulatta) were challenged with peripheral blood mononuclear cells from another animal diagnosed with acquired immune deficiency syndrome (AIDS). Half of the simian immunodeficiency virus (SIV)-vaccinated animals challenged were protected, whereas unprotected vaccinates progressed as rapidly to AIDS. Protection was unrelated to either total antibody titers to human cells, used in the production of the vaccine, to HLA antibodies or to virus neutralizing activity. However, analysis of the serotype of each animal revealed that all animals protected against cell-associated virus challenge were those which were SIV vaccinated and which shared a particular major histocompatibility complex (MHC) class I allele (Mamu-A26) with the donor of the infected cells. Cytotoxic T lymphocytes (CTL) specific for SIV envelope protein were detected in three of four protected animals vs. one of four unprotected animals, suggesting a possible role of MHC class I-restricted CTL in protection from infected blood cells. These findings have possible implications for the design of vaccines for intracellular pathogens such as human immunodeficiency virus (HIV).
Collapse
|
65
|
Slierendregt BL, Otting N, Jonker M, Bontrop RE. Gel electrophoretic analysis of rhesus macaque major histocompatibility complex class II DR molecules. Hum Immunol 1994; 40:33-40. [PMID: 8045791 DOI: 10.1016/0198-8859(94)90019-1] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
Rhesus macaque MHC class II DR molecules were isolated from radiolabeled B-cell line extracts by immunoprecipitation with the mAbs 7.3.19.1 and B8.11.2 and subsequently analyzed by 2D-gel electrophoresis. The B-cell lines used for this study were obtained from monkeys that are homozygous for the Mamu-DR region as defined by serologic techniques. Some of these animals have been selectively bred and originate from consanguineous matings. These analyses show that monkeys with the same allotyping may express different types of DR molecules. As in humans, the number of DR molecules expressed per haplotype is not constant and varies from 1 to 3, depending on the serologically defined Mamu-DR specificity, whereas it has been shown that the number of Mamu-DRB genes present per haplotype varies from 2 to 6. Therefore the present study also demonstrates that some of the rhesus macaque DR regions contain one or more pseudogenes.
Collapse
|
66
|
Slierendregt BL, Otting N, van Besouw N, Jonker M, Bontrop RE. Expansion and contraction of rhesus macaque DRB regions by duplication and deletion. JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 1994; 152:2298-307. [PMID: 8133043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Previous sequence analysis of the rhesus macaque MHC (MhcMamu) class II DRB region has allowed the detection of at least 34 alleles belonging to different lineages. In this communication, 36 new Mamu-DRB alleles are reported. The gene content of the DRB region has been determined for several homozygous animals of consanguineous origin. As in other primates, the number of DRB genes present per haplotype is not constant, varying from two to six genes in rhesus macaques. Six major groups of DRB haplotypes have been defined in our rhesus macaque colony. Two haplotype groups were found to carry, as well as other Mamu-DRB genes, two genes that cluster into distinct HLA-DRB1 lineages. In one of these two groups, a haplotype harbors another two sets of DRB alleles that belong to the Mhc-DRB6 and -DRB*W6 lineages, respectively. Such a haplotype was probably generated by duplication, and our data suggest that after this particular expansion of the DR region, one of the duplicated Mamu-DRB6 alleles was the target of an Alu insertion. Although certain transspecies allelic lineages are evolutionarily stable, and have been conserved for at least 36 million years, the rhesus macaque class II haplotypes differ significantly from those found in humans, chimpanzees, and gorillas. Mhc-DRB regions are therefore comparatively unstable over longer evolutionary time spans, with regard to both the number of genes and the gene content, and must have been subjected to expansion and contraction.
Collapse
|
67
|
Slierendregt BL, Otting N, van Besouw N, Jonker M, Bontrop RE. Expansion and contraction of rhesus macaque DRB regions by duplication and deletion. THE JOURNAL OF IMMUNOLOGY 1994. [DOI: 10.4049/jimmunol.152.5.2298] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Abstract
Previous sequence analysis of the rhesus macaque MHC (MhcMamu) class II DRB region has allowed the detection of at least 34 alleles belonging to different lineages. In this communication, 36 new Mamu-DRB alleles are reported. The gene content of the DRB region has been determined for several homozygous animals of consanguineous origin. As in other primates, the number of DRB genes present per haplotype is not constant, varying from two to six genes in rhesus macaques. Six major groups of DRB haplotypes have been defined in our rhesus macaque colony. Two haplotype groups were found to carry, as well as other Mamu-DRB genes, two genes that cluster into distinct HLA-DRB1 lineages. In one of these two groups, a haplotype harbors another two sets of DRB alleles that belong to the Mhc-DRB6 and -DRB*W6 lineages, respectively. Such a haplotype was probably generated by duplication, and our data suggest that after this particular expansion of the DR region, one of the duplicated Mamu-DRB6 alleles was the target of an Alu insertion. Although certain transspecies allelic lineages are evolutionarily stable, and have been conserved for at least 36 million years, the rhesus macaque class II haplotypes differ significantly from those found in humans, chimpanzees, and gorillas. Mhc-DRB regions are therefore comparatively unstable over longer evolutionary time spans, with regard to both the number of genes and the gene content, and must have been subjected to expansion and contraction.
Collapse
|
68
|
Abreu P, Adam W, Adye T, Agasi E, Aleksan R, Alekseev GD, Allport P, Almehed S, Almeida Junior FML, Alvsvaag SJ, Amaldi U, Andreazza A, Antilogus P, Apel WD, Apsimon RJ, Arnoud Y, Åsman B, Augustin JE, Augustinus A, Baillon P, Bambade P, Barao F, Barate R, Barbiellini G, Bardin DY, Barker GJ, Baroncelli A, Barring O, Barrio JA, Bartl W, Bates MJ, Battaglia M, Baubillier M, Becks KH, Begalli M, Beilliere P, Belokopytov Y, Beltran P, Benvenuti AC, Berggren M, Bertrand D, Bianchi F, Bigi M, Bilenky MS, Billoir P, Bjarne J, Bloch D, Blocki J, Blyth S, Bocci V, Bogolubov PN, Bolognese T, Bonesini M, Bonivento W, Booth PSL, Borisov G, Bosio C, Bostjancic B, Bosworth S, Botner O, Bouquet B, Bourdarios C, Bowcock TJV, Bozzo M, Braibant S, Branchini P, Brand KD, Brenner RA, Briand H, Bricman C, Brillault L, Brown RCA, Brunet JM, Bugge L, Buran T, Buys A, Buytaert JAMA, Caccia M, Calvi M, Rozas AJC, Campion R, Camporesi T, Canale V, Cabkocak K, Cao F, Carena F, Carrilho P, Carroll L, Cases R, Caso C, Castillo Gimenez MV, Cattai A, Cavallo FR, Cerrito L, Chabaud V, Chan A, Charpentier P, Chauveau J, Checchia P, Chelkov GA, Chevalier L, Chliapnikov P, Chorowicz V, Chrin JTM, Cindro V, Collins P, Contreras JL, Contri R, Cortina E, Cosme G, Couchot F, Crawley HB, Crennell D, Crosetti G, Crosetti G, Maestro JC, Czellar S, Dahl-Jensen E, Dahm J, Dalmagne B, Dam M, Damgaard G, Daubie E, Daum A, Dauncey PD, Davenport M, Davies J, Silva W, Defoix C, Delpierre P, Demaria N, Angelis A, Boeck H, Boer W, Brabandere S, Clercq C, Fez Laso MDM, Vaissiere C, Lotto D, Min A, Paula L, Dijkstra H, Ciaccio L, Djama F, Dolbeau J, Donszelmann M, Doroba K, Dracos M, Drees J, Dris M, Dufour Y, Dupont F, Edsall D, Eek LO, Ehret R, Ekelof T, Ekspong G, Peisert AE, Elsing M, Engel JP, Ershaidat N, Santo ME, Falaleev V, Fassouliotis D, Feindt M, Fenyuk A, Ferrer A, Filipas TA, Firestone A, Foeth H, Fokitis E, Fontanelli F, Forbes KAJ, Formenti F, Fousset JL, Francon S, Franek B, Frenkiel P, Fries DC, Frodesen AG, Fruhwirth R, Fulda-Quenzer F, Fustenau H, Fuster J, Gamba D, Gandelman M, Garcia C, Garcia J, Gaspar C, Gasparini U, Gavillet P, Gazis EN, Gerber JP, Giacomelli P, Gillespie D, Gokieli R, Golob B, Golovatyuk VM, Cadenas JJGY, Gopal G, Gorn L, Gorski M, Gracco V, Grard F, Graziani E, Grosdidier G, Grossetete B, Gunnarsson P, Guy J, Haedinger U, Hahn F, Hahn M, Hahn S, Haider S, Hajduk Z, Hakansson A, Hallgren A, Hamacher K, Hamel De Monchenault G, Hao W, Harris FJ, Hedberg V, Henriques R, Hernandez JJ, Hernando JA, Herquet P, Herr H, Hessing TL, Higgins CO, Higon E, Hilke HJ, Hill TS, Hodgson SD, Holmogren SO, Holt PJ, Holthuizen D, Honore PF, Houlden M, Hrubec J, Huet K, Hultqvist K, Ioannou P, Iversen PS, Jackson JN, Jacobsson R, Jalocha P, Jarlskog G, Jarry P, Jean-Marie B, Johansson EK, Jonker M, Jonsson L, Juillot P, Kaiser M, Kalmus G, Kapusta F, Karlsson M, Karvelas E, Katsanevas S, Katsoufis EC, Keranen R, Khomenko BA, Khovanski NN, King B, Kjaer NJ, Klein H, Klovning A, Kluit P, Koch-Mehrin A, Koehne JH, Koene B, Kokkionias P, Koratzinos M, Korcyl K, Korytov AV, Kostioukhine V, Kourkoumelis C, Kouznetsov O, Kramer PH, Krammer M, Kreuter C, Krolikowski J, Kronkvist I, Krupinski W, Kulka K, Kurvinen K, Lacasta C, Lambropoulos C, Lamsa JW, Lanceri L, Langefeld P, Lapin V, Last I, Laugier JP, Lauhakangas R, Leder G, Ledroit F, Leitner R, Lemoigne Y, Lemonne J, Lenzen G, Lepeltier V, Lesiak T, Levy JM, Lieb E, Liko D, Linder R, Lipnicka A, Lippi I, Loerstad B, Lokajicek M, Loken JG, Lopez-Feernandez A, Lopez Aguera MA, Los M, Loukas D, Lozano JJ, Lutz P, Lyons L, Maehlum G, Maillard J, Maio A, Maltezos A, Mandl F, Marco J, Marechal B, Margoni M, Marin JC, Mariotti C, Markou A, Maron T, Marti S, Martinez-Rivero C, Martinez-Vidal F, Matorras F, Mattekuzzi C, Mathiae G, Mazzucato M, Cubbin MM, Kay RM, Nulty RM, Medbo J, Meroni C, Meyer WT, Michelotto M, Migliore E, Mikulec I, Mirabito L, Mitaroff WA, Mitselmakher GV, Mjoernmark U, Moa T, Moeller R, Moenig K, Monge MR, Morettini P, Mueller H, Murray WJ, Muryn B, Myatt G, Naraghi F, Navarria FL, Negri P, Nemecek S, Neumann W, Neumeister N, Nicolaidou R, Nielsen BS, Nikolaenko V, Nilsen PES, Niss P, Nomerotski A, Novak M, Obraztsov V, Olshevski AG, Orava R, Ostankov A, Osterberg K, Ouraou A, Paganini P, Paganoni M, Pain R, Palka H, Papadopouliou TD, Page L, Parodi F, Parodi A, Pegoraro M, Pennanen J, Peralta L, Perevozchikov V, Pernegger H, Perrotta A, Petridou C, Petrolini A, Piana G, Pierre F, Pimenta M, Plaszczynski S, Podobrin O, Pol ME, Polok G, Poropat P, Pozdniakov V, Prest M, Privitera P, Pullia A, Radojicic D, Ragazzi S, Rahmani H, Ratoff PN, Read AL, Reale M, Rebechi P, Redaelli NG, Regler M, Renton PB, Resvanis LK, Richard F, Richardson J, Ridky J, Rinaudo G, Rinaudo A, Romero A, Roncagliolo I, Ronchese P, Rosenberg EI, Rosso E, Roudeau P, Rovelli T, Ruckstuhl W, Ruhklmann-Keleider V, Ruizt A, Rybicki K, Saarikko H, Sacquin Y, Sajot G, Salt J, Sanchez J, Sannino M, Schael S, Schneider H, Schyns MAE, Sciolla G, Scuri F, Segar AM, Seitz A, Sekulin R, Seufert R, Shellard RC, Siccama I, Siegrist P, Sciolla G, Simonetto F, Sisakian AN, Skjevling G, Smadja G, Smirnova O, Smith GR, Sonsnowski R, Souza-Santos D, Spassov T, Spassov E, Spiriti E, Squarcia S, Staeck H, Stanescu C, Stanescu C, Stapnes S, Stavropoulos G, Stepaniak K, Stichelbaut F, Strauss J, Straver J, Stugu R, Szczekowski M, Szeptycka M, Szymanski P, Tabarelli T, Tchikilev O, Theodosiou GE, thome Z, Tilquin A, Timmermans J, Timofeev VG, Tkatchev LG, Todorov T, Toet DZ, Tomaradze A, Torassa E, Tortora L, Treille D, Trischuk W, Tristram G, Troncon C, Tsirou A, Tsyganov EN, Turala M, Turluer ML, Tuuva T, Tyapkin IA, Tyndel M, Tzamarias S, Ueberschaer B, Ueberschaer S, Ulland O, Uvarov V, Vallazza G, Ferrer JA, Velde C, Apeldoorn GW, Dam P, Hejiden M, Doninck WK, Eldik J, Vaz P, Vengi G, Ventura L, Venus W, Verbeure F, Verlato M, Vertogradov LS, Vilanova D, Vincent P, Vitale L, Vlasov E, Vodopyanov AS, Vollmer M, Voutilainen M, Wahlen H, Walck C, Waldner F, Wehr A, Weierstall M, Weilhmmer P, Wetherell AM, Wickens JH, Wielers M, Wilkinson GR, Williams WSC, Winter M, Witek M, Wormser G, Woschnagg K, Zaitsev A, Zalewska A, Zalewski P, Zavrtanik D, Zevgolatakos E, Zimin NI, Zito M, Zontar D, Zuberi R, Zumerle G. A precision measurement of the average lifetime ofB hadrons. ACTA ACUST UNITED AC 1994. [DOI: 10.1007/bf01577539] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
69
|
Jonker M, Slingerland W, Treacy G, van Eerd P, Pak KY, Wilson E, Tam S, Bakker K, Lobuglio AF, Rieber P. In vivo treatment with a monoclonal chimeric anti-CD4 antibody results in prolonged depletion of circulating CD4+ cells in chimpanzees. Clin Exp Immunol 1993; 93:301-7. [PMID: 8103714 PMCID: PMC1554916 DOI: 10.1111/j.1365-2249.1993.tb08176.x] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Abstract
Chimeric M-T412 (cM-T412), an anti-CD4 antibody, was tolerated in chimpanzees at a dosage of 5 mg/kg per day for up to 7 consecutive days, or 5 mg/kg per dose, twice weekly for 4 weeks. All cM-T412-treated chimpanzees showed a prolonged CD4-cell depression. Weak chimpanzee antibody responses to chimeric M-T412 were observed. One of the chimpanzees on the biweekly dosage regimen exhibited a hypersensitivity reaction immediately after receiving its seventh dose. Following supportive treatment, the animal recovered and remained asymptomatic during the non-treatment observation period. The hypersensitivity reaction was not an unexpected response considering the animal received repeated intermittent i.v. administration of a foreign protein. This animal also showed a chimpanzee antibody response to chimeric M-T412 after the seventh dose. Chimeric M-T412 also induced an anti-cM-T412 response in some of the other animals. The level of this response was lower than the anti-mouse responses observed in animals treated with murine anti-CD4. Moreover, the anti-cM-T412 response was mainly directed to idiotypic determinants. The decrease in CD4+ cells observed for all chimeric M-T412-treated chimpanzees is an expected effect of the anti-CD4 antibody. The duration of this CD4+ cell decrease is, however, much longer than observed for other CD4-specific MoAbs described. No selective loss of either memory or naive CD4+ cells was observed after either the single, 7-day or twice-weekly treatments. The CD4+ cell depression was reversible, although individual variation in time to recovery was observed. Therefore, cM-T412 could be a good candidate for clinical use in autoimmune conditions.
Collapse
|
70
|
Bakker NP, Van Besouw N, Groenestein R, Jonker M, Hart LA. The anti-arthritic and immunosuppressive effects of cyclosporin A on collagen-induced arthritis in the rhesus monkey. Clin Exp Immunol 1993; 93:318-22. [PMID: 8370160 PMCID: PMC1554915 DOI: 10.1111/j.1365-2249.1993.tb08179.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023] Open
Abstract
The influence of cyclosporin A (CsA) on type II collagen-induced arthritis (CIA) in the rhesus monkey has been investigated. CsA was administered subcutaneously in a dose of 25 mg/kg per day during 9-18 days and additionally 12.5 mg/kg per day for 7 days. At this dosing regime no significant alterations of haematologic parameters were found, indicating that the toxicity of CsA was negligible. Administration of CsA after onset of arthritis had no beneficial effect, but when given between immunization and manifestation of clinical symptoms, CIA could be prevented completely. Moreover, these monkeys became resistant to the disease, because no arthritic activity could be observed upon a booster immunization with type II collagen (CII). The suppression of disease by CsA is reflected in reduced antibody levels to CII.
Collapse
|
71
|
Slierendregt BL, Kenter M, Otting N, Anholts J, Jonker M, Bontrop RE. Major histocompatibility complex class II haplotypes in a breeding colony of chimpanzees (Pan troglodytes). TISSUE ANTIGENS 1993; 42:55-61. [PMID: 8266319 DOI: 10.1111/j.1399-0039.1993.tb02237.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
|
72
|
Hart BA, Bakker NP, Jonker M, Bontrop RE. Resistance to collagen-induced arthritis in rats and rhesus monkeys after immunization with attenuated type II collagen. Eur J Immunol 1993; 23:1588-94. [PMID: 8325336 DOI: 10.1002/eji.1830230729] [Citation(s) in RCA: 28] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Immunization of susceptible rodent or primate species with type II collagen (b-CII) from bovine origin induces type II collagen-induced arthritis (CIA). The disease is characterized as a systemic polyarthritis associated with humoral and cellular autoimmunity to CII and shares similarity with human arthritic diseases. The objective of this study was to develop a procedure for induction of resistance to CIA in animals, which possess a certain major histocompatibility complex phenotype that makes them prone to develop CIA (susceptible). It is shown that by immunization with an attenuated form of CII, in which arthritogenic epitopes have been destroyed by heat denaturation, disease resistance is induced in a susceptible inbred rat strain (RT-1u) and in an outbred population of susceptible rhesus monkeys (lacking the Mamu-A26 allele). In both species the disease resistance is connected with modulation of anti-CII autoantibodies of the IgM isotype. This protocol may provide a basis for effective and safe methods to induce protection to autoimmune arthritis in those subjects that are genetically prone to develop such a disease.
Collapse
|
73
|
Abreu P, Adam W, Adye T, Agasi E, Alekseev GD, Algeri A, Allen P, Almehed S, Alvsvaag SJ, Amaldi U, Anassontzis EG, Andreazza A, Antilogus P, Apel WD, Apsimon RJ, Åsman B, Augustin JE, Augustinus A, Baillon P, Bambade P, Barao F, Barate R, Barbiellini G, Bardin DY, Barker GJ, Baroncelli A, Barring O, Barrio JA, Bartl W, Bates MJ, Battaglia M, Baubillier M, Becks KH, Beeston CJ, Begalli M, Beilliere P, Belokopytov Y, Beltran P, Benedic D, Benvenuti AC, Berggren M, Bertrand D, Bianchi F, Bilenky MS, Billoir P, Bjarne J, Bloch D, Blyth S, Bocci V, Bogolubov PN, Bolognese T, Bonesini M, Bonivento W, Booth PSL, Borgeaud P, Borisov G, Borner H, Bosio C, Bostjancic B, Bosworth S, Botner O, Bouquet B, Bourdarios C, Bowcock TJV, Bozzo M, Braibant S, Branchini P, Brand KD, Brenner RA, Briand H, Bricman C, Brown RCA, Brummer N, Brunet JM, Bugge L, Buran T, Burmeister H, Buytaert JAMA, Caccia M, Calvi M, Camacho Rozas AJ, Campion R, Camporesi T, Canale V, Cao F, Carena F, Carroll L, Caso C, Castillo Gimenez MV, Cattai A, Cavallo FR, Cerrito L, Chabaud V, Chan A, Charpentier P, Chaussard L, Chauveau J, Checchia P, Chelkov GA, Chevalier L, Chliapnikov P, Chorowicz V, Chrin JTM, Clara MP, Collins P, Contreras JL, Contri R, Cortina E, Cosme G, Couchot F, Crawley HB, Crennell D, Crosetti G, Crozon M, Maestro JC, Czellar S, Dahl-Jensen E, Dalmagne B, Dam M, Damgaard G, Darbo G, Daubie E, Daum A, Dauncey PD, Davenport M, David P, Davies J, Silva W, Defoix C, Delikaris D, Delorme S, Delpierre P, Demaria N, Angelis A, Beer M, Boeck H, Boer W, Clercq C, Fez Laso MDM, Groot N, Vaissiere C, Lotto B, Min A, Dijkstra H, Ciaccio L, Djama F, Dolbeau J, Donszelmann M, Doroba K, Dracos M, Drees J, Dris M, Dufour Y, Eek LO, Eerola PAM, Ehret R, Ekelof T, Ekspong G, Elliot Peisert A, Engel JP, Ershaidat N, Fassouliotis D, Feindt M, Fernandez Alonso M, Ferrer A, Filippas TA, Firestone A, Foeth H, Fokitis E, Fontanelli F, Forbes KAJ, Fousset JL, Francon S, Franek B, Frenkiel P, Fries DC, Frodesen AG, Fruhwirth R, Fulda-Quenzer F, Furnival K, Furstenau H, Fuster J, Galeazzi G, Gamba D, Garcia C, Garcia J, Gaspar C, Gasparini U, Gavillet P, Gazis EN, Gerber JP, Giacomelli P, Gokieli R, Golob B, Golovatyuk VM, Gomez Y Cadenas JJ, Goobar A, Gopal G, Gorski M, Gracco V, Grant A, Grard F, Graziani E, Grosdidier G, Gross E, Grosse-Wiesmann P, Grossetete B, Gumenyuk S, Guy J, Haedinger U, Hahn F, Hahn M, Haider S, Hakansson A, Hallgren A, Hamacher K, Hamel De Monchenault G, Hao W, Harris FJ, Henkes T, Hernandez JJ, Herquet P, Herr H, Hessing TL, Hietanen I, Higgins CO, Higon E, Hilke HJ, Hodgson SD, Hofmokl T, Holmes R, Holmgren SO, Holthuizen D, Honore PF, Hooper JE, Houlden M, Hrubec J, Huet K, Hulth PO, Hultqvist K, Ioannou P, Isenhower D, Iversen PS, Jackson JN, Jalocha P, Jarlskog G, Jarry P, Jean-Marie B, Johansson EK, Johnson D, Jonker M, Jonsson L, Juillot P, Kalkanis G, Kalmus G, Kapusta F, Karlsson M, Karvelas E, Katsanevas S, Katsoufis EC, Keranen R, Kesteman J, Khomenko BA, Khovanski NN, King B, Kjaer NJ, Klein H, Klempt W, Klovning A, Kluit P, Koch-Mehrin A, Koehne JH, Koene B, Kokkinias P, Kopf M, Korcyl K, Korytov AV, Kostioukhine V, Kourkoumelis C, Kouznetsov O, Kramer PH, Krolikowski J, Kronkvist I, Kruener-Marquis U, Krupinski W, Kulka K, Kurvinen K, Lacasta C, Lambropoulos C, Lamsa JW, Lanceri L, Lapin V, Laugier JP, Lauhakangas R, Leder G, Ledroit F, Leitner R, Lemoigne Y, Lemonne J, Lenzen G, Lepeltier V, Lesiak T, Levy JM, Lieb E, Liko D, Lindgren J, Lindner R, Lipniacka A, Lippi I, Loerstad B, Lokajicek M, Loken JG, Lopez-Fernandez A, Lopez Aguera MA, Los M, Loukas D, Lozano JJ, Lutz P, Lyons L, Maehlum G, Maillard J, Maltezos A, Mandl F, Marco J, Margoni M, Marin JC, Markou A, Maron T, Marti S, Mathis L, Matorras F, Matteuzzi C, Matthiae G, Mazzucato M, McCubbin M, McKay R, McNulty R, Meola G, Meroni C, Meyer WT, Michelotto M, Mikulec I, Mirabito L, Mitaroff WA, Mitselmakher GV, Mjoernmark U, Moa T, Moeller R, Moenig K, Monge MR, Morettini P, Mueller H, Murray WJ, Muryn B, Myatt G, Navarria FL, Negri P, Nielsen BS, Nijjhar B, Nikolaenko V, Nilsen PES, Niss P, Obraztsov V, Olshevski AG, Orava R, Ostankov A, Osterberg K, Ouraou A, Paganoni M, Pain R, Palka H, Papadopoulou TD, Pape L, Passeri A, Pegoraro M, Pennanen J, Perevozchikov V, Pernicka M, Perrotta A, Petridou C, Petrolini A, Petrovykh L, Pettersen TE, Pierre F, Pimenta M, Pingot O, Plaszczynski S, Pol ME, Polok G, Poropat P, Privitera P, Pullia A, Radojicic D, Ragazzi S, Rahmani H, Ratoff PN, Read AL, Redaelli NG, Regler M, Reid D, Renton PB, Resvanis LK, Richard F, Richardson M, Ridky J, Rinaudo G, Roditi I, Romero A, Roncagliolo I, Ronchese P, Ronnqvist C, Rosenberg EI, Rossi S, Rossi U, Rosso E, Roudeau P, Rovelli T, Ruckstuhl W, Ruhlmann-Kleider V, Ruiz A, Rybicki K, Saarikko H, Sacquin Y, Sajot G, Salt J, Sanchez J, Sannino M, Schael S, Schneider H, Schulze B, Schyns MAE, Sciolla G, Scuri F, Segar AM, Sekulin R, Sessa M, Sette G, Seufert R, Shellard RC, Siccama I, Siegrist P, Simonetti S, Simonetto F, Sisakian AN, Skaali TB, Skjevling G, Smadja G, Smith GR, Sosnowski R, Spassoff TS, Spiriti E, Squarcia S, Staeck H, Stanescu C, Stapnes S, Stavropoulos G, Stichelbaut F, Stocchi A, Strauss J, Straver J, Strub R, Szczekowski M, Szeptycka M, Szymanski P, Tabarelli T, Tavernier S, Tchikilev O, Theodosiou GE, Tilquin A, Timmermans J, Timofeev VG, Tkatchev LG, Todorov T, Toet DZ, Toker O, Torassa E, Tortora L, Treille D, Trevisan U, Trischuk W, Tristram G, Troncon C, Tsirou A, Tsyganov EN, Turala M, Turluer ML, Tuuva T, Tyapkin IA, Tyndel M, Tzamarias S, Ueberschaer S, Ullaland O, Uvarov V, Valenti G, Vallazza E, Valls Ferrer JA, Velde C, Apeldoorn GW, Dam P, Heijden M, Doninck WK, Vaz P, Vegni G, Ventura L, Venus W, Verbeure F, Vertogradov LS, Vilanova D, Vincent P, Vitale L, Vlasov E, Vodopyanov AS, Vollmer M, Voulgaris G, Voutilainen M, Vrba V, Wahlen H, Walck C, Waldner F, Wayne M, Wehr A, Weierstall M, Weilhammer P, Werner J, Wetherell AM, Wickens JH, Wikne J, Wilkinson GR, Williams WSC, Winter M, Witek M, Wormald D, Wormser G, Woschnagg K, Yamdagni N, Yepes P, Zaitsev A, Zalewska A, Zalewski P, Zavrtanik D, Zevgolatakos E, Zhang G, Zimin NI, Zito M, Zuberi R, Zukanovich Funchal R, Zumerle G, Zuniga J. A measurement ofB meson production and lifetime usingDl − events inZ 0 decays. ACTA ACUST UNITED AC 1993. [DOI: 10.1007/bf01565048] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
74
|
Slierendregt BL, Otting N, Jonker M, Bontrop RE. Major histocompatibility complex class II DQ diversity in rhesus macaques. TISSUE ANTIGENS 1993; 41:178-85. [PMID: 8103245 DOI: 10.1111/j.1399-0039.1993.tb01999.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
By the use of restriction fragment length polymorphism analysis 10 Taq I fragments could be identified for the MhcMamu-DQA1 region. A strong correlation exists between the occurrence of Mamu-DQA1/Taq I fragments and Mamu-DQA1 allelic sequence variation. Most restriction fragments correspond with a unique Mamu-DQA1 allele, with one exception being the Taq I 4.5 kb fragment that is associated with two Mamu-DQA1 alleles. The RFLP technique allowed the identification of 15 Mamu-DQB1/Taq I restriction fragments, whereas sequence analysis has permitted the characterization of at least 20 different Mamu-DQB1 alleles. In this communication two unpublished Mamu-DQB1 sequences are described. For Mamu-DQB1, on only four occasions was it possible to demonstrate a correlation between a certain fragment and an allelic sequence. These analyses, performed on material from truly homozygous animals, allowed us to define which combinations of Mamu-DQA1 and -DQB1 molecules form heterodimers at the cell surface. In addition, these studies are helpful in typing non-human primate species that are used in biomedical research.
Collapse
|
75
|
Kenter M, Otting N, de Weers M, Anholts J, Reiter C, Jonker M, Bontrop RE. Mhc-DRB and -DQA1 nucleotide sequences of three lowland gorillas. Implications for the evolution of primate Mhc class II haplotypes. Hum Immunol 1993; 36:205-18. [PMID: 8340229 DOI: 10.1016/0198-8859(93)90127-m] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
Mhc-DRB and -DQA1 second-exon and -DRB 3'-untranslated-region nucleotide sequences of three lowland gorillas with no known family relationship with each other and of two HLA homozygous typing cell lines were determined and compared with published primate Mhc-DRB and -DQA1 sequences. Eleven distinct MhcGogo-DRB second-exon sequences were found, which represent the gorilla counterparts of the HLA-DRB1*03, -DRB1*10, -DRB3, -DRB5, and -DRB6 allelic lineages. One Gogo-DRB second-exon sequence does not have an obvious human counterpart and is tentatively designated Gogo-DRBY*01. The gorilla equivalents of the HLA-DRB2 and -DRB8 loci were identified as judged on Mhc-DRB 3'-untranslated-region sequences. In addition, four different Gogo-DQA1 alleles belonging to three different allelic lineages were detected. The Mhc-DRB-DQA1 haplotypes of these gorillas were deduced based on the obtained Mhc-DRB and -DQA1 sequences and the two published Mhc-DRB haplotypes of the lowland gorilla Sylvia. All deduced Gogo-DRB-DQA1 haplotypes show gene constellations different from known HLA-DRB-DQA1 haplotypes, while some of the Gogo-DRB haplotypes presented here contain more DRB genes than the HLA-DRB haplotypes. Based on phylogenetic trees, bootstrap analyses, and the gorilla, chimpanzee, and human Mhc-DRB haplotypes described, we propose that at least two Mhc-DRB loci, here tentatively designated Mhc-DRBI and -DRBII, existed on an ancient primate Mhc-DRB haplotype. The Mhc-DRB1*01, -DRB1*02 (-DRB1*15 and -DRB1*16), -DRB1*03 (-DRB1*03, -DRB1*08, -DRB1*11, -DRB1*12, -DRB1*13, and DRB1*14), and -DRB1*10 allelic lineages and -DRB3 and -DRBY loci probably evolved from the hypothetical primate Mhc-DRBI locus, whereas the present primate Mhc-DRB2, -DRB4, and -DRB6 loci originate from the ancient Mhc-DRBII locus of this core primate Mhc-DRB haplotype.
Collapse
|